Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/14596
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKumar, Baldev-
dc.contributor.authorJindal, Ankur-
dc.contributor.authorPandey, Dilip Kumar-
dc.contributor.authorBhatt, Shvetank-
dc.date.accessioned2012-08-29T04:54:56Z-
dc.date.available2012-08-29T04:54:56Z-
dc.date.issued2012-09-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/14596-
dc.description625-632en_US
dc.description.abstractThe present study was designed to investigate the putative antidepressant and anxiolytic-like effects of N-n-Butylquinoxalin-2-carboxamide (4n), a novel 5-HT3 receptor antagonist, with an optimal log P (2.01) and pA2 value (7.3) greater than ondansetron (6.9) using rodent behavioural models of depression and anxiety. Acute treatment of 4n (1-4 mg/kg, ip) in mice produced antidepressant-like effect in forced swim test (FST) without affecting the baseline locomotion in actophotometer test in mice. 4n (2-4 mg/kg, ip) treatment also potentiated the 5-hydroxytryptophan (5-HTP) induced head twitch response in mice. Further, 4n (1-4 mg/kg, ip) treatment antagonized reserpine induced hypothermia in rats. Chronic treatment (14 days) with 4n (1-4 mg/kg) and paroxetine (10 mg/kg) significantly attenuated the behavioural anomalies induced by bilateral olfactory bulbectomy in rats in modified open field paradigm. An anxiogenic-like behaviour was induced by light alone as the stimulus using light-dark aversion test. 4n (2-4 mg/kg, ip) treatment significantly increased no. of transitions between dark and lit area and the time spent in the lit area. In conclusion, these preliminary investigations confirm that 4n exhibited antidepressant and anxiolytic-like effects in rodent models of depression and anxiety. en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJEB Vol.50(09) [September 2012]en_US
dc.subject5-HT3 receptor antagonisten_US
dc.subjectDepressionen_US
dc.subjectForced swim testen_US
dc.subjectLight-dark aversion testen_US
dc.subjectN-n-butylquinoxalin-2-carboxamideen_US
dc.subjectOlfactory bulbectomyen_US
dc.titleAntidepressant and anxiolytic-like effects of 4n, a novel 5-HT3 receptor antagonist using behaviour based rodent modelsen_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.50(09) [September 2012]

Files in This Item:
File Description SizeFormat 
IJEB 50(9) 625-632.pdf93.07 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.